Literature DB >> 11777678

Elevated blood pressure among U.S. adults with diabetes, 1988-1994.

Linda S Geiss1, Deborah B Rolka, Michael M Engelgau.   

Abstract

BACKGROUND: Recent guidelines and clinical trial results emphasize the importance of controlling blood pressure among people with diabetes. We estimated the prevalence of elevated blood pressure among U.S. adults with diagnosed diabetes, and examined the extent to which elevated blood pressure is being treated and controlled.
METHODS: The Third National Health and Nutrition Examination Survey (1988-1994), a probability survey of the civilian, non-institutionalized population of the United States, consisted of an interview and physical examination, which included blood pressure measurement. Survey participants included 1507 adults (aged > or = 18 years) with self-reported diabetes. Among people with self-reported diabetes, we estimated elevated blood pressure (mean blood pressure of > or = 130/85 mm Hg or use of antihypertensive medication); awareness (prior diagnosis of hypertension); treatment (antihypertensive medication use); and control (mean blood pressure of <130/85 or <140/90).
RESULTS: In the 1988-1994 period, 71% (95% confidence interval [CI]=+/-4.4%) of all U.S. adults with diabetes had elevated blood pressure. The prevalence of elevated blood pressure increased with age and was high among both men and women and among Mexican Americans, non-Hispanic blacks, and non-Hispanic whites. Among those with elevated blood pressure, 71% (95% CI=+/-4.1%) were aware and 57% (95% CI=+/-4.2%) were treated, but only 12% (95% CI=+/-3.2%) had mean blood pressure <130/85 and 45% (95% CI=+/-4.9%) had mean blood pressure <140/90. Control of blood pressure was least common among older people.
CONCLUSIONS: All people with diabetes-regardless of age, gender, and race and ethnicity-may benefit from efforts to prevent hypertension. The control of elevated blood pressure is inadequate and broad-based efforts are needed to improve blood pressure control.

Entities:  

Mesh:

Year:  2002        PMID: 11777678     DOI: 10.1016/s0749-3797(01)00399-3

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  33 in total

1.  Glucose estimation and prediction through meal responses using ambulatory subject data for advisory mode model predictive control.

Authors:  Rachel Gillis; Cesar C Palerm; Howard Zisser; Lois Jovanovic; Dale E Seborg; Francis J Doyle
Journal:  J Diabetes Sci Technol       Date:  2007-11

2.  Trends in hypertension management in Type I diabetes across Europe, 1989/1990 - 1997/1999.

Authors:  S S Soedamah-Muthu; H M Colhoun; H Abrahamian; N N Chan; R Mangili; G P Reboldi; J H Fuller
Journal:  Diabetologia       Date:  2002-09-07       Impact factor: 10.122

3.  Design, feasibility, and acceptability of an intervention using personal digital assistant-based self-monitoring in managing type 2 diabetes.

Authors:  Mary Ann Sevick; Susan Zickmund; Mary Korytkowski; Beth Piraino; Susan Sereika; Shannon Mihalko; Linda Snetselaar; Phyllis Stumbo; Leslie Hausmann; Dianxu Ren; Rita Marsh; Teresa Sakraida; Jolynn Gibson; Mehry Safaien; Terry J Starrett; Lora E Burke
Journal:  Contemp Clin Trials       Date:  2007-09-26       Impact factor: 2.226

4.  Cognition and incident dementia hospitalization: results from the atherosclerosis risk in communities study.

Authors:  Andrea L C Schneider; Rebecca F Gottesman; Thomas Mosley; Alvaro Alonso; David S Knopman; Josef Coresh; A Richey Sharrett; Elizabeth Selvin
Journal:  Neuroepidemiology       Date:  2012-10-22       Impact factor: 3.282

5.  Gender Differences in Cognitive Function among Older Mexican Immigrants.

Authors:  Maria Casanova; Emma Aguila
Journal:  J Econ Ageing       Date:  2019-11-07

Review 6.  Hypertension management in patients with diabetic nephropathy.

Authors:  Anthony L McCall
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

Review 7.  Optimizing target-organ protection in patients with diabetes mellitus: angiotensin-converting enzyme inhibitors or angiotensin receptor blockers?

Authors:  Wei X Lu; Jay Lakkis; Matthew R Weir
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

Review 8.  Are low target blood pressure goals justified in persons with diabetes mellitus?

Authors:  Errol D Crook; Latha Velusamy
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

9.  The effects of rosiglitazone on inflammatory biomarkers and adipokines in diabetic, hypertensive patients.

Authors:  Milan Gupta; Hwee Teoh; Mahesh Kajil; Michelle Tsigoulis; Adrian Quan; Manoela Fb Braga; Subodh Verma
Journal:  Exp Clin Cardiol       Date:  2012

10.  Insufficient control of blood pressure and incident diabetes.

Authors:  Raffaele Izzo; Giovanni de Simone; Marcello Chinali; Guido Iaccarino; Valentina Trimarco; Francesco Rozza; Renata Giudice; Bruno Trimarco; Nicola De Luca
Journal:  Diabetes Care       Date:  2009-02-17       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.